Effects of vitamin D supplementation on alveolar macrophage gene expression: Preliminary results of a randomized, controlled trial

Multidisciplinary Respiratory Medicine

Volumn 9, Issue 1, 2014, Pages

  Gerke, Alicia K ^a   Pezzulo, Alejandro A ^a   Tang, Fan ^b   Cavanaugh, Joseph E ^b   Bair, Thomas B ^b   Phillips, Emily ^a   Powers, Linda S ^a   Monick, Martha M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Alveolar; Gene expression; Immunity; Innate; Macrophages; Randomized controlled; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; MELANOCORTIN 3 RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 2; PLACEBO; PROTEIN HOMER 2; PURINERGIC P2Y RECEPTOR;

ADULT; ARTICLE; BRONCHOSCOPY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; INDIGESTION; INTERVENTION STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UPREGULATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 84901922142     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-9-18     Document Type: Article

References (22)

1. Beard JA, Bearden A, Striker R: Vitamin D and the anti-viral state. J Clin Virol 2011, 50:194-200.
2. Martineau AR: Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc Nutr Soc 2012, 71:84-89.
3. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E: Epidemic influenza and vitamin D. Epidemiol Infect 2006, 134:1129-1140. (Pubitemid 44614932)
4. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, Coolen J, Mathieu C, Decramer M, Lambrechts D: Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010, 65:215-220.
5. Youssef DA, Miller CW, El-Abbassi AM, Cutchins DC, Cutchins C, Grant WB, Peiris AN: Antimicrobial implications of vitamin D. Dermatoendocrinol 2011, 3:220-229.
6. Hewison M: Vitamin D, and the intracrinology of innate immunity. Mol Cell Endocrinol 2010, 321:103-111.
7. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
8. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, Lee ZW, Lee SH, Kim JM, Jo EK: Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microb 2009, 6:231-243.
9. Graff JW, Powers LS, Dickson AM, Kim J, Reisetter AC, Hassan IH, Kremens K, Gross TJ, Wilson ME, Monick MM: Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PloS One 2012, 7:e44066.
10. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC: Vitamin D and inflammation. Joint Bone Spine 2010, 77:552-557.
11. Bozzetto S, Carraro S, Giordano G, Boner A, Baraldi E: Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy 2012, 67: 10-17.
12. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW: Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008, 181:7090-7099.
13. Jorde R, Witham M, Janssens W, Rolighed L, Borchhardt K, de Boer IH, Grimnes G, Hutchinson MS: Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials. Scand J Infect Dis 2012, 44:126-132.
14. Rees JR, Hendricks K, Barry EL, Peacock JL, Mott LA, Sandler RS, Bresalier RS, Goodman M, Bostick RM, Baron JA: Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clin Infect Dis 2013, 57:1384-1392.
15. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H: Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010, 91:1255-1260.
16. Blaszczyk J, Coillie EV, Proost P, Damme JV, Opdenakker G, Bujacz GD, Wang JM, Ji X: Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry 2000, 39:14075-14081.
17. Liu H, Liu Z, Chen J, Chen L, He X, Zheng R, Yang H, Song P, Weng D, Hu H, Fan L, Xiao H, Kaufmann SH, Ernst J, Ge B: Induction of CCL8/MCP-2 by mycobacteria through the activation of tlr2/pi3k/akt signaling pathway. PloS One 2013, 8:e56815.
18. Maddocks S, Scandurra GM, Nourse C, Bye C, Williams RB, Slobedman B, Cunningham AL, Britton WJ: Gene expression in HIV-1/mycobacterium tuberculosis co-infected macrophages is dominated by M. Tuberculosis. Tuberculosis 2009, 89:285-293.
19. Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, Ravn P, TBNet: Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008, 32:1607-1615.
20. Riek AE, Oh J, Bernal-Mizrachi C: 1,25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients. J Steroid Biochem Mol Biol 2013, 136:309-312.
21. Gao D, Trayhurn P, Bing C: 1,25-dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes 2013, 37:357-365.
22. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M: Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009, 179:843-850.